Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05821530 · ClinicalTrials.gov registry record · NA
HFIT Versus TENS Study for Chronic Low Back and Knee Pain
A NA study of Chronic Pain and Knee Pain Chronic, sponsored by Hinge Health.
- Active
- Registry status
- NA
- Development phase
- 325
- Enrollment target
- 1
- Study location
NCT05821530: Active NA study of Chronic Pain and Knee Pain Chronic, sponsored by Hinge Health.
NCT05821530 is a NA study of Chronic Pain and Knee Pain Chronic that is active but no longer recruiting, run by Hinge Health. The registered enrollment target is 325 participants, below the 771-participant average among 301 other Chronic Pain trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05821530, a NA study of Chronic Pain and Knee Pain Chronic, is active but no longer recruiting, sponsored by Hinge Health.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 325 participants
- Enrollment target
- 1
- Study location
Study Summary
A high-frequency impulse therapy (HFIT) device (Enso, San Francisco, CA) is a portable device for the treatment of musculoskeletal pain. This three-arm randomized controlled trial study compares a HFIT group to a standard transcutaneous electrical nerve stimulator (TENS) group and a control group.
Primary Outcome
Pain will be measured by the Numeric Pain Rating Scale, ranging from 0 (no pain) to 100 (worst possible pain). The minimal clinically important difference (MCID) of pain will be achieved (0/1) if there is at least a 34% or 23 point improvement, as based on literature.
Conditions Studied
Interventions
- OTHER Control
- DEVICE TENS
- DEVICE HFIT
Study Locations (1)
California
- Hinge Health, Inc - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 325 participants |
| Start Date | 2023-04-24 |
| Est. Completion | 2023-06-30 |
| Phase | NA |
What the registry record for NCT05821530 still lists
NCT05821530 is an interventional study that assigns participants to a tested intervention. The registered 325 participants enrollment target is mid-sized for trials with a published cap, below the 771-participant average among 301 other Chronic Pain trials with a reported enrollment target (58% lower).
The record links to 3 conditions, with Chronic Pain appearing as the primary indexed condition, and to 3 interventions - of which Control is the first listed.
NCT05821530 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05821530 about?
NCT05821530 is a clinical study titled "HFIT Versus TENS Study for Chronic Low Back and Knee Pain". A high-frequency impulse therapy (HFIT) device (Enso, San Francisco, CA) is a portable device for the treatment of musculoskeletal pain. This three-arm randomized controlled trial study compares a HFIT group to a standard transcutaneous electrical nerve stimulator (TENS) group and a control group.
What is the current status of trial NCT05821530?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 325 participants. The study started on 2023-04-24. Estimated completion is 2023-06-30.
What conditions does trial NCT05821530 study?
This clinical trial studies the following conditions: Chronic Pain, Knee Pain Chronic, Back Pain, Low.
What interventions are being tested in trial NCT05821530?
The interventions under investigation include: Control (OTHER), TENS (DEVICE), HFIT (DEVICE).
Who is sponsoring clinical trial NCT05821530?
This trial is sponsored by Hinge Health, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05821530 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05821530's enrollment target sits among peer trials
325 47th of 301 higher than 255 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
RECRUITING · NA
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
RECRUITING · NA
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02543983 · 325 participants · Phase 2
Neurobiology of Suicide
- NCT03016819 · 325 participants · Phase 3
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
- NCT03288207 · 325 participants · NA
Tailoring Mobile Health Technology to Reduce Obesity and Improve Cardiovascular Health in Resource-Limited Neighborhood Environments
- NCT04986657 · 325 participants · NA
Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI